Bramacare, a UK specialist eating disorder service, has launched AMY – an AI-powered clinical platform designed to bring a patient’s entire clinical picture into a single live view and help clinicians intervene earlier before patients reach crisis point.
The platform consolidates National Early Warning Score, ECG readings, blood results, weight trajectories, medication changes, and dietary intake in real time. Its AI engine runs continuously, built in alignment with the Medical Emergencies in Eating Disorders (MEED) guidelines, to spot dangerous patterns – such as weight drops and missed appointments – before they become emergencies. It also automates administrative tasks like reporting and record-keeping to free up clinical time.
Eating disorders disproportionately affect women – roughly 75% of those diagnosed are female – and at least 1.25 million people in the UK are now living with one, with rates rising rapidly among young people. Demand for NHS services continues to grow, with increasing referrals and mounting pressure on specialist teams.
The platform is named after Amy Dingle, Bramacare’s first patient in 2017, whose experience shaped its development. “For anyone going through what I went through, it’s incredibly important that the people caring for you have the right information at the right time and are fully coordinated in their approach,” said Dingle. “AMY will give clinical teams the tools and insight they need to deliver the highest standard of care, providing patients with what I was fortunate to receive – a real chance at recovery.”
“Amy was our first patient, and her experience showed us what good care should look like – coordinated, consistent, and centred around the individual,” said Bramacare CEO Laetitia Beaujard-Ramoo.
AMY is currently in structured clinical evaluation ahead of UKCA Class IIb conformity assessment and will begin NHS trust pilots in 2026.
